Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Locatelli

Showing results (291-300 of 377) with videos related to

Pageof 38
Sort By:
Blood Purification|January 10, 2008
The MPO Study: just a European HEMO Study or something very different?Francesco Locatelli, Adelheid Gauly, Stanislaw Czekalski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Iron biologyLucia Del Vecchio, Domenico Girelli, Francesca Vinchi, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2010
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathyClaudio Pozzi, Simeone Andrulli, Antonello Pani, et al.
Kidney International. Supplement|October 16, 2004
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy TrialLawrence G Hunsicker, Robert C Atkins, Julia B Lewis, et al.
Kidney International|July 31, 2014
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortalityGeorge R Bailie, Maria Larkina, David A Goodkin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 18, 2017
Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPSFrancesco Locatelli, Angelo Karaboyas, Ronald L Pisoni, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 7, 2017
Assessment of intradialysis calcium mass balance by a single pool variable-volume calcium kinetic modelSalvatore di Filippo, Fabio Carfagna, Vincenzo la Milia, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 22, 2011
Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practicesRonald L Pisoni, Jennifer L Bragg-Gresham, Douglas S Fuller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 2013
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)George R Bailie, Maria Larkina, David A Goodkin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2005
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathyRobert C Atkins, Esther M Briganti, Julia B Lewis, et al.
Pageof 38

Showing results (291-300 of 377) with videos related to

Sort By:
Pageof 38
Blood Purification|January 10, 2008
The MPO Study: just a European HEMO Study or something very different?Francesco Locatelli, Adelheid Gauly, Stanislaw Czekalski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2024
Iron biologyLucia Del Vecchio, Domenico Girelli, Francesca Vinchi, et al.
Journal of the American Society of Nephrology : JASN|July 17, 2010
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathyClaudio Pozzi, Simeone Andrulli, Antonello Pani, et al.
Kidney International. Supplement|October 16, 2004
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy TrialLawrence G Hunsicker, Robert C Atkins, Julia B Lewis, et al.
Kidney International|July 31, 2014
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortalityGeorge R Bailie, Maria Larkina, David A Goodkin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 18, 2017
Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPSFrancesco Locatelli, Angelo Karaboyas, Ronald L Pisoni, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 7, 2017
Assessment of intradialysis calcium mass balance by a single pool variable-volume calcium kinetic modelSalvatore di Filippo, Fabio Carfagna, Vincenzo la Milia, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 22, 2011
Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practicesRonald L Pisoni, Jennifer L Bragg-Gresham, Douglas S Fuller, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 2013
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)George R Bailie, Maria Larkina, David A Goodkin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2005
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathyRobert C Atkins, Esther M Briganti, Julia B Lewis, et al.
Pageof 38